CIK 0001583771 · Non-accelerated filer<br>Smaller reporting company
Hepion Pharmaceuticals, Inc.
Sign in to watch- Tickers
- HEPA CTRVP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 462783806
- Phone
- 732-902-4000
- Business address
- 34 SHREWSBURY AVE., SUITE 1D, RED BANK, NJ, 07701
- Former names
- ContraVir Pharmaceuticals, Inc.
Securities
- HEPA Common stock OTC
- CTRVP Common stock OTC
- Open-market buys, last 90 days
- $10,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$10,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 28 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-23 | Liddy James Gordon Director | Grant or award · Stock Options | +510,000 | 809,000 | ||
| 2026-10-23 | Fisher Danina Director | Grant or award · Stock Options | +510,000 | 809,000 | ||
| 2026-10-23 | Stetz Gary S. Chief Financial Officer | Grant or award · Stock Options | +1,530,000 | 2,875,500 | ||
| 2026-10-23 | LoPriore Vincent S Executive Chairman | Grant or award · Stock Options | +1,530,000 | 2,875,500 | ||
| 2026-10-23 | Purcell Michael J. Director | Grant or award · Stock Options | +510,000 | 809,000 | ||
| 2026-10-23 | Appajosyula Sireesh Chief Executive Officer | Grant or award · Stock Options | +1,530,000 | 2,875,500 | ||
| 2026-10-23 | LoPriore Chase VP, Corp. Dev. | Grant or award · Stock Options | +1,530,000 | 2,875,500 | ||
| 2026-10-23 | Stetz Gary S. II Director | Grant or award · Stock Options | +510,000 | 809,000 | ||
| 2026-09-29 | Fisher Danina Director | Purchase | +200,000 | $0.05 | $10K | 200,000 |
| 2026-09-29 | Fisher Danina Director | Purchase · Warrants | +200,000 | 200,000 | ||
| 2026-09-03 | LoPriore Vincent S Executive Chairman | Purchase · Warrants | +12,500,000 | 22,500,000 | ||
| 2026-08-19 | Purcell Michael J. Director | Grant or award · Stock Options | +299,000 | 299,000 | ||
| 2026-08-19 | Stetz Gary S. Interim CEO | Grant or award · Stock Options | +1,345,500 | 1,345,500 | ||
| 2026-08-19 | LoPriore Vincent S Executive Chairman | Grant or award · Stock Options | +1,345,500 | 1,345,500 | ||
| 2026-08-19 | LoPriore Chase VP, Corp. Dev. | Grant or award · Stock Options | +1,345,500 | 1,345,500 | ||
| 2026-08-19 | Fisher Danina Director | Grant or award · Stock Options | +299,000 | 299,000 | ||
| 2026-08-19 | Liddy James Gordon Director | Grant or award · Stock Options | +299,000 | 299,000 | ||
| 2026-08-19 | Appajosyula Sireesh Chief Operating Officer | Grant or award · Stock Options | +1,345,500 | 1,345,500 | ||
| 2026-08-19 | Stetz Gary S. II Director | Grant or award · Stock Options | +299,000 | 299,000 | ||
| 2026-08-03 | Stetz Gary S. II Director | Purchase | +500,000 | $0.05 | $25K | 500,000 |
Page 1 of 6 · 119 trades